Americas corporate citadels are becoming less impregnable A more aggressive stance by shareholders is opening new avenues to hostile bids and ushering in radical changes to boards and management teams Take Allergan Inc Since  the maker of Botox has adopted a number of shareholder proposals that make it easier for investors to replace its directors The pharmaceutical companys board was lukewarm about the moves which had been championed by a small shareholder and backed by some large funds according to public filings